Option chain shows key data for Sartorius's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sartorius.

Sartorius (OTC:SARTF) Stock, Option Chain

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Biotech

News

Health Care

Rumors

Small Cap

Movers

Trading Ideas

General

MRVI

SARTF

Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) reportedly attracted takeover interest from Thomas H. Lee Partners with a non-binding offer, though the offer price could not be learned.

Maravai is a U.S. provider of capping reagents for COVID-19 vaccines. 

Maravai LifeSciences Shares Fall After Rejecting Potential Takeover By Private Equity

Earnings

Government

Regulations

Retail Sales

Travel

Treasuries

Economics

Tech

GDDY

JBLU

SIEGY

The United States kicks off the week as much of Europe is recognizing the Christmas holiday on Monday. Despite the approaching New Year’s holiday, the U.S. markets are open all week. Between Christmas and New Year’s Eve trading volumes tend to be about 30% lower because many investors take time off.

Holiday Shopping Saw Growth in Apparel and Jewelry

Intraday Update

Markets

AACTF

ABBRF

ADBE

ADUS

AEHR

AFGC

AGNC

AMXEF

AMXVF

APPF

APPN

APTO

ARCAY

ARCE

ARCVF

ASHTY

ASNB

ATGFF

ATRC

ATVI

AZRE

BCYC

BILI

BLDP

BOWFF

BURL

BWXT

BXMT

CDLX

CDPYF

CEVA

CFBK

CFFA

CLGX

CLHRF

CLPBF

CLPBY

CMCLF

CMLEF

CMXHF

CNNE

COST

CPRT

CPWHF

CTAS

CTXXF

CWEN

CWEN-A

CWST

DBOEY

DIMC

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

DNNGY

DOCU

DOOR

DRTGF

EDPFY

Stocks That Hit 52-Week Highs On Tuesday

Sartorius AG

Longleaf Partners Fund Q2 2024 Commentary

Invesco International Diversified Fund Q2 2024 Review

Franklin Growth Fund Q2 2024 Commentary

BlackRock Health Sciences Term Trust Q2 2024 Commentary

RGA Investment Advisors Q2 2024 Investment Commentary

American Century Focused International Growth Fund Q2 2024 Commentary

Sartorius Aktiengesellschaft GAAP EPS of €0.26, revenue of €655.4M

Sartorius Aktiengesellschaft reports nine-month results

Sartorius Aktiengesellschaft (SARTF) Q3 2024 Earnings Call Transcript

Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage

Comments

Sartorius

Sartorius (SARTF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga